Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT04982419
- Phase
- PHASE2/PHASE3
- Status
- Recruiting
Conditions
- Acute Kidney Injury
- Contrast Induced Nephropathy
- Coronary Angiography
- Heart Failure
- Percutaneous Coronary Intervention
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Remote ischemic preconditioning — DEVICE3 cycles of blood pressure cuff inflations to occlusive pressure of 200 mmHg for 5 minutes and deflation for 5 minutes
- Sham remote ischemic conditioning — DEVICE3 cycles of blood pressure cuff inflations to non-occlusive pressure of 60 mmHg for 5 minutes and deflation for 5 minutes (Control)
Study Details
This is a prospective, double-blind, sham-controlled, multicenter, randomized clinical trial is to study the effects of remote ischemic preconditioning on contrast-associated acute kidney injury, functional capacity, and major adverse kidney events in in patients with congestive heart failure undergoing cardiac catheterization and/or percutaneous coronary intervention.
Key Dates
- Start date
- Nov 1, 2021
- Status verified
- Dec 2025
- Primary completion
- Mar 31, 2028
- Completion
- Mar 31, 2029
Study Design
- Enrollment
- 240 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Active Comparator: Remote ischemic preconditioning3 cycles of blood pressure cuff inflations to occlusive pressure of 200 mmHg for 5 minutes and deflation for 5 minutes
- Sham Comparator: Sham remote ischemic preconditioning3 cycles of blood pressure cuff inflations to non-occlusive pressure of 60 mmHg for 5 minutes and deflation for 5 minutes (Control)
Primary Outcome Measure
Contrast-associated acute kidney injury [ Time Frame: 24 and 48 hours time points ]
Central Contacts
- Oladipupo Olafiranye, MD MS(214) 857-2923
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA | Pittsburgh | Pennsylvania | 15240 | |
| VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX | Dallas | Texas | 75216-7167 | Oladipupo Olafiranye, MD MS (PRINCIPAL_INVESTIGATOR) |
| Hunter Holmes McGuire VA Medical Center, Richmond, VA | Richmond | Virginia | 23249-0001 |
Find similar trials in Pittsburgh, PA
By condition
By specialty
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- Identification of Genomic Predictors of Adverse Events After Cardiac SurgeryRecruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Get With The Guidelines-Heart Failure RegistryRecruiting · American Heart Association · Dallas, Texas
- Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by AnthracyclinesPHASE1 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas